These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8413750)

  • 21. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M; Allington N
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
    Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
    J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity.
    Suputtitada A; Suwanwela NC
    Disabil Rehabil; 2005 Feb; 27(4):176-84. PubMed ID: 15824048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum treatment for post-stroke spasticity: low dose regime.
    Viriyavejakul A; Vachalathiti R; Poungvarin N
    J Med Assoc Thai; 1998 Jun; 81(6):413-22. PubMed ID: 9676073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of neural lesion type on botulinum toxin dosage: a retrospective chart review.
    Phadke CP; Davidson C; Ismail F; Boulias C
    PM R; 2014 May; 6(5):406-11. PubMed ID: 24211697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity.
    Kong KH; Neo JJ; Chua KS
    Clin Rehabil; 2007 Jan; 21(1):28-35. PubMed ID: 17213238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of stretch reflex threshold in spasticity: effect of botulinum toxin injections.
    Stampacchia G; Bradaschia E; Rossi B
    Arch Ital Biol; 2004 May; 142(3):265-73. PubMed ID: 15260380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH; Whyte J; Wannstedt G; Ellis CA
    Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased residual urine volume after local injection of botulinum A toxin].
    Schnider P; Berger T; Schmied M; Fertl L; Auff E
    Nervenarzt; 1995 Jun; 66(6):465-7. PubMed ID: 7637833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
    Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
    Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders.
    Yablon SA
    Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
    Kawamura A; Campbell K; Lam-Damji S; Fehlings D
    Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].
    Sławek J; Madaliński MH; Maciag-Tymecka I; Duzyński W
    Pol Merkur Lekarski; 2005 Mar; 18(105):298-302. PubMed ID: 15997637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and clinical changes in upper limb spastic patients treated with botulinum toxin (BTX).
    Panizza M; Castagna M; di Summa A; Saibene L; Grioni G; Nilsson J
    Funct Neurol; 2000; 15(3):147-55. PubMed ID: 11062843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin type A treatment of upper limb spasticity].
    Wissel M; Wissel J
    Wien Klin Wochenschr; 2001; 113 Suppl 4():16-9. PubMed ID: 15506047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative measurement of poststroke spasticity and response to treatment with botulinum toxin: a 2-patient case report.
    Cousins E; Ward AB; Roffe C; Rimington LD; Pandyan AD
    Phys Ther; 2009 Jul; 89(7):688-97. PubMed ID: 19482901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.